Concepedia

A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis

Seung‐Jung Park, Won Heum Shim, David Sai Wah Ho, Albert E. Raizner, Seong‐Wook Park, Myeong‐Ki Hong, Cheol Whan Lee, Donghoon Choi, Yangsoo Jang, Ricky Lam,

New England Journal of Medicine · 2003 · 456 citations · 25 references

DOIFull text

Open access

Abstract

Paclitaxel-eluting stents used with conventional antiplatelet therapy effectively inhibit restenosis and neointimal hyperplasia, with a safety profile similar to that of standard stents.

References

25

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa et al. · New England Journal of Medicine · 2002 · 4K citations · Full text

Promotion of microtubule assembly in vitro by taxol

Peter B. Schiff, Jane Fant, Susan Band Horwitz · Nature · 1979 · 3.6K citations

, , +4

Patterns and Mechanisms of In-Stent Restenosis

Rainer Hoffmann, Gary S. Mintz, G Dussaillant et al. · Circulation · 1996 · 1.2K citations

Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery

Dorothea I. Axel, W Kunert, Christoph Göggelmann et al. · Circulation · 1997 · 769 citations

Clinical toxicities encountered with paclitaxel (Taxol).

Rowinsky Ek, Eisenhauer Ea, Chaudhry et al. · PubMed · 1993 · 697 citations